MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3

Molecular Cancer

Volumn 14, Issue 1, 2015, Pages

  Sun, Lijuan ^a   Liu, Bodu ^a   Lin, Zhaoyu ^a   Yao, Yandan ^a   Chen, Yanyang ^b   Li, Yang ^b   Chen, Jianing ^a   Yu, Dongsheng ^b   Tang, Zhangui ^c   Wang, Bosheng ^c   Zeng, Shuguang ^d   Fan, Song ^a   Wang, Youyuan ^a   Li, Yilin ^e   Song, Erwei ^a   Li, Jinsong ^a  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

^e Xaverian Brothers High School   (United States)

Author keywords

Adenoid cystic carcinoma; ITGB3; Metastasis; miR 320a; Prognosis

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA3 INTEGRIN; MICRORNA; MICRORNA 320A; UNCLASSIFIED DRUG; TUMOR MARKER;

ADENOID CYSTIC CARCINOMA; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL ADHESION ASSAY; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUCIFERASE ASSAY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS INHIBITION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; SALIVARY ADENOID CYSTIC CARCINOMA; SALIVARY GLAND CARCINOMA; TUMOR INVASION; TUMOR XENOGRAFT; ANIMAL TISSUE; CLINICAL FEATURE; GENE; GENE TARGETING; HUMAN CELL; HUMAN TISSUE; ITGB3 GENE; RNA ANALYSIS;

MUS;

EID: 84928881932     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/s12943-015-0344-y.     Document Type: Article

References (36)

1. Dodd RL, Slevin NJ. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol. 2006;42:759-69.
2. Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984;54:1062-9.
3. Tang Y, Liang X, Zheng M, Zhu Z, Zhu G, Yang J, et al. Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma. Oral Oncol. 2010;46:311-6.
4. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006;127:679-95.
5. Rapidis AD, Givalos N, Gakiopoulou H, Faratzis G, Stavrianos SD, Vilos GA, et al. Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol. 2005;41:328-35.
6. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005;65:9628-32.
7. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004;303:83-6.
8. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007;131:1109-23.
9. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, et al. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res. 2009;15:3998-4008.
10. Yu F, Deng H, Yao H, Liu Q, Su F, Song E. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene. 2010;29:4194-204.
11. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009;11:1487-95.
12. Paterson EL, Kazenwadel J, Bert AG, Khew-Goodall Y, Ruszkiewicz A, Goodall GJ. Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression. Neoplasia. 2013;15:180-91.
13. Liu MX, Zhou KC, Cao Y. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer. Mol Cancer. 2014;13:245.
14. Couzin J. Cancer biology. A new cancer player takes the stage. Science. 2005;310:766-7.
15. Mitani Y, Roberts DB, Fatani H, Weber RS, Kies MS, Lippman SM, et al. MicroRNA profiling of salivary adenoid cystic carcinoma: association of miR-17-92 upregulation with poor outcome. PLoS One. 2013;8:e66778.
16. Deng X, Li Q, Hoff J, Novak M, Yang H, Jin H, et al. Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis. Neoplasia. 2012;14:678-89.
17. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science. 1995;268:233-9.
18. Schwartz W, Schaller M, M. G. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol. 1995;11:549-99.
19. Hu Y, Ylivinkka I, Chen P, Li L, Hautaniemi S, Nyman TA, et al. Netrin-4 promotes glioblastoma cell proliferation through integrin beta4 signaling. Neoplasia. 2012;14:219-27.
20. Guan JL. Role of focal adhesion kinase in integrin signaling. Int J Biochem Cell Biol. 1997;29:1085-96.
21. Vuori K, Hirai H, Aizawa S, Rouslahti E. Introduction of p130cas signaling complex formation upon integrin-mediated cell adhesion: a role for Src family kinases. Mol Cell Biol. 1996;16:2606-13.
22. Zha RP, Guo WJ, Zhang ZF, Qiu ZP, Wang QF, Ding J, et al. Genome-Wide Screening Identified That miR-134 Acts as a Metastasis Suppressor by Targeting Integrin beta 1 in Hepatocellular Carcinoma. PLoS One. 2014;9:e87665.
23. Zhao YY, Miao G, Li Y, Isaji T, Gu JG, Li J, et al. Microrna 130b Suppresses Migration and Invasion of Colorectal Cancer Cells through Downregulation of Integrin beta 1. PLoS One. 2014;9:e87938.
24. Sun JY, Huang Y, Li JP, Zhang X, Wang L, Meng YL, et al. MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting beta-catenin. Biochem Biophys Res Commun. 2012;420:787-92.
25. Schaar DG, Medina DJ, Moore DF, Strair RK, Ting Y. miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. Exp Hematol. 2009;37:245-55.
26. Zhang Y, He X, Liu Y, Ye Y, Zhang H, He P, et al. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer. Oncol Rep. 2012;27:685-94.
27. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005;438:685-9.
28. Jeyaseelan K, Herath WB, Armugam A. MicroRNAs as therapeutic targets in human diseases. Expert Opin Ther Targets. 2007;11:1119-29.
29. Li J, Smyth P, Flavin R, Cahill S, Denning K, Aherne S, et al. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol. 2007;7:36.
30. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum microRNAs are promising novel biomarkers. PLoS One. 2008;3:e3148.
31. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513-8.
32. Guan X, Qiu W, He R, Lin G, X. Z. The selection of highly lung metastatic salivary cystic carcinoma clone. Chin J Stomatol. 1996;31:74-7.
33. Li S, Liu X, Zhang K. Establishment of a human cancer cell line from adenoid cystic carcinoma of the minor salivary gland. Chin J Stomatol. 1990;25:29-31.
34. Sun L, Yao Y, Liu B, Lin Z, Lin L, Yang M, et al. MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene. 2012;31:432-45.
35. Chen J, Yao Y, Gong C, Yu F, Su S, Chen J, et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell. 2011;19:541-55.
36. Song E, Chen J, Ouyang N, Su F, Wang M, Heemann U. Soluble Fas ligand released by colon adenocarcinoma cells induces host lymphocyte apoptosis: an active mode of immune evasion in colon cancer. Br J Cancer. 2001;85:1047-54.